VHL is a tumor suppressor gene whose mutation is associated with an autosomal dominant disease named von Hippel–Lindau syndrome that results in the development of retinal hemangioblastomas, central nervous system (CNS) hemangioblastomas, PPGLs, and renal carcinomas [17]. This evidence concerns the gene VHL and von Hippel-Lindau disease.